44,721 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by Sienna Gestion

Sienna Gestion purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 44,721 shares of the medical research company’s stock, valued at approximately $5,794,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Seven Eight Capital LP acquired a new position in shares of Agilent Technologies during the second quarter worth approximately $401,000. CCLA Investment Management increased its stake in Agilent Technologies by 1.2% during the 2nd quarter. CCLA Investment Management now owns 782,917 shares of the medical research company’s stock valued at $102,253,000 after purchasing an additional 9,178 shares in the last quarter. Blair William & Co. IL raised its holdings in Agilent Technologies by 5.0% during the second quarter. Blair William & Co. IL now owns 20,560 shares of the medical research company’s stock worth $2,665,000 after buying an additional 985 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in shares of Agilent Technologies by 13.3% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 28,992 shares of the medical research company’s stock valued at $3,727,000 after buying an additional 3,399 shares in the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. grew its holdings in shares of Agilent Technologies by 9.6% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 26,685 shares of the medical research company’s stock valued at $3,459,000 after buying an additional 2,330 shares during the last quarter. 87.42% of the stock is owned by institutional investors.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. TD Cowen upped their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Wells Fargo & Company assumed coverage on Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price on the stock. Robert W. Baird lowered their price target on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a research report on Thursday, May 30th. UBS Group lifted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $135.00 target price (down previously from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $141.60.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $139.01 on Thursday. The business’s 50 day simple moving average is $137.50 and its 200 day simple moving average is $139.25. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.35. The company has a market cap of $40.56 billion, a price-to-earnings ratio of 32.86, a PEG ratio of 6.43 and a beta of 1.05. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.43 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.